Cargando…
Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015
Shigellosis outbreaks caused by Shigella with decreased susceptibility to azithromycin (DSA-Shigella) among men who have sex with men (MSM) have been reported worldwide. We describe sexual health indicators and antimicrobial drug resistance for shigellosis cases in Minnesota, USA. We analyzed a samp...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101095/ https://www.ncbi.nlm.nih.gov/pubmed/32186495 http://dx.doi.org/10.3201/eid2604.191031 |
_version_ | 1783511549153902592 |
---|---|
author | Eikmeier, Dana Talley, Pamela Bowen, Anna Leano, Fe Dobbins, Ginette Jawahir, Selina Gross, Annastasia Huspeni, Dawn La Pointe, Allison Meyer, Stephanie Smith, Kirk |
author_facet | Eikmeier, Dana Talley, Pamela Bowen, Anna Leano, Fe Dobbins, Ginette Jawahir, Selina Gross, Annastasia Huspeni, Dawn La Pointe, Allison Meyer, Stephanie Smith, Kirk |
author_sort | Eikmeier, Dana |
collection | PubMed |
description | Shigellosis outbreaks caused by Shigella with decreased susceptibility to azithromycin (DSA-Shigella) among men who have sex with men (MSM) have been reported worldwide. We describe sexual health indicators and antimicrobial drug resistance for shigellosis cases in Minnesota, USA. We analyzed a sample of isolates received during 2012–2015 and cross-referenced cases with the Minnesota Department of Health Sexually Transmitted Disease Database to ascertain patients’ HIV status and recent chlamydia, gonorrhea, and syphilis infections. Of 691 Shigella isolates, 46 (7%) were DSA-Shigella; 91% of DSA-Shigella patients were men, of whom 60% were living with HIV. Among men, those with DSA-Shigella infection had greater odds of living with HIV, identifying as MSM, or having a recent diagnosis of a sexually transmitted disease. DSA-Shigella was associated with MSM, HIV infection, and recent sexually transmitted disease. To decrease spread of DSA-Shigella, interventions targeted at communities at high risk are needed. |
format | Online Article Text |
id | pubmed-7101095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-71010952020-04-03 Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015 Eikmeier, Dana Talley, Pamela Bowen, Anna Leano, Fe Dobbins, Ginette Jawahir, Selina Gross, Annastasia Huspeni, Dawn La Pointe, Allison Meyer, Stephanie Smith, Kirk Emerg Infect Dis Synopsis Shigellosis outbreaks caused by Shigella with decreased susceptibility to azithromycin (DSA-Shigella) among men who have sex with men (MSM) have been reported worldwide. We describe sexual health indicators and antimicrobial drug resistance for shigellosis cases in Minnesota, USA. We analyzed a sample of isolates received during 2012–2015 and cross-referenced cases with the Minnesota Department of Health Sexually Transmitted Disease Database to ascertain patients’ HIV status and recent chlamydia, gonorrhea, and syphilis infections. Of 691 Shigella isolates, 46 (7%) were DSA-Shigella; 91% of DSA-Shigella patients were men, of whom 60% were living with HIV. Among men, those with DSA-Shigella infection had greater odds of living with HIV, identifying as MSM, or having a recent diagnosis of a sexually transmitted disease. DSA-Shigella was associated with MSM, HIV infection, and recent sexually transmitted disease. To decrease spread of DSA-Shigella, interventions targeted at communities at high risk are needed. Centers for Disease Control and Prevention 2020-04 /pmc/articles/PMC7101095/ /pubmed/32186495 http://dx.doi.org/10.3201/eid2604.191031 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Synopsis Eikmeier, Dana Talley, Pamela Bowen, Anna Leano, Fe Dobbins, Ginette Jawahir, Selina Gross, Annastasia Huspeni, Dawn La Pointe, Allison Meyer, Stephanie Smith, Kirk Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015 |
title | Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015 |
title_full | Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015 |
title_fullStr | Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015 |
title_full_unstemmed | Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015 |
title_short | Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012–2015 |
title_sort | decreased susceptibility to azithromycin in clinical shigella isolates associated with hiv and sexually transmitted bacterial diseases, minnesota, usa, 2012–2015 |
topic | Synopsis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101095/ https://www.ncbi.nlm.nih.gov/pubmed/32186495 http://dx.doi.org/10.3201/eid2604.191031 |
work_keys_str_mv | AT eikmeierdana decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT talleypamela decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT bowenanna decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT leanofe decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT dobbinsginette decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT jawahirselina decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT grossannastasia decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT huspenidawn decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT lapointeallison decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT meyerstephanie decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 AT smithkirk decreasedsusceptibilitytoazithromycininclinicalshigellaisolatesassociatedwithhivandsexuallytransmittedbacterialdiseasesminnesotausa20122015 |